This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
21 Sep 2020

Metrics Contract Services begins $10M plant expansion

Metrics Contract Services' Greenville, North Carolina facility.

Clients set to benefit immediately through "higher yields" and "improved potent handling".

Metrics Contract Services, a full-service global contract development and manufacturing organization (CDMO) and a subsidiary of Mayne Pharma Group, has started constructing the expansion of its novel oral solid dosage manufacturing facility expansion in Greenville, North Carolina.

The $10-million investment will add 3,760 sq. ft of production space to the current facility, providing added flexibility and capacity to the CDMO and its clients.

The expansion consists of three new rooms: one dispensing/flex room, one tablet press room and one flex room to accommodate the company’s growing portfolio of commercial services following sustained increase in demand from clients for high potent handling capabilities.

New equipment also forms part of the investment and includes a Fette FE55 tablet press, a Bosch 720 encapsulator, which both offer containment capabilities for the safe handling of potent products, and a weigh and dispense isolator.

The new equipment is ideal for the small batch size and high changeover products which the company's clients require. John Ross, President at Mayne Pharma US and Metrics Contract Services, said: “Our clients will see immediate benefits through higher yields and improved potent handling.”

The company said it recognized that customers' commercial requirements often demanded increased flexibility within production suites. This expansion will cater for those needs by creating more spaces where equipment trains can be tailored to the applicable process.

The expansion project which has been in development over the last 6 months is expected to be complete and fully operational by February 2021.

Ross added: “This is a significant investment for the business and reflects our commitment to increasing our novel oral solid manufacturing capabilities and providing our clients with quality services from initial concept through to global commercialization."

The company is now actively considering the next phase of investment, which may include further packaging and adjacent formulation technologies.

Mentioned Companies
Metrics Contract Services
View company profile

Related News